-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Will mosaic vaccine immunogens expand immune response breadth to rival HIV-1 strain diversity?
Tracey A Day, Cecilia A Morgan, James G Kublin
Editorial: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation